Toward effective prescription of inhaled corticosteroids in chronic airway disease

The airway diseases asthma and COPD affect millions of individuals worldwide. These diseases are major determinants of chronic morbidity and mortality, and represent a substantial public health burden. Despite differences in etiology, clinical characteristics, and pathophysiology, both conditions share important features, such as airway obstruction and chronic airway inflammation. As a result of modern lifestyle, the incidence of both diseases is steadily increasing worldwide and effective preventive and treatment strategies are unmet needs